Picture Berlin Partner Special Topic Well-trained Professionals 650x100px

Person › Details

Chris Maggos (Cohesion Bureau (brand of BioConfidant))

Maggos, Chris (BioConfidant / Cohesion Bureau 202303 Managing Director + Founder before LifeSci Advisors + Addex)

	Organisation	Cohesion Bureau (brand of BioConfidant)
	Group	BioConfidant (Group)
	Former/major organisation	LifeSci Advisors LLC
	Group	LifeSci (Group)
	Product	public relations / investor relations / marcom (services)
	Product 2	LIFE SCIENCES

Record changed: 2023-07-19

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Chris Maggos

[1] EG 427. (7/13/23). "Press Release: EG 427 Announces Final Series A Closing, Achieving €18 Million in Total Funds Raised". Paris....
[2] AC Immune S.A.. (6/27/23). "Press Release: AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease". Lausanne....
[3] Kinarus Therapeutics Holding AG. (8/22/22). "Press Release: Kinarus Announces the Issuance of Convertible Notes of up to CHF 20 Million to an Entity Managed by Yorkville [ not for any jurisdiction where unlawful]". Basel....
[4] Abivax S.A.. (7/25/18). "Press Release: Abivax Secures up to EUR 20m Debt Financing from Kreos Capital". Paris....
[5] Neovacs S.A.. (2/22/18). "Press Release: Neovacs Strengthens Its Intellectual Property in the USA". Paris & Boston, MA....
[6] Abivax S.A.. (12/7/17). "Press Release: Abivax to Present in Plenary Session at the 8th International Conference on HIV Persistence during Therapy". Paris....
[7] Abivax S.A.. (9/28/17). "Press Release: Abivax Secures an Equity Line Financing with Kepler Cheuvreux. Cash for Operations Extended until End of Q2 2019". Paris....
[8] Abivax S.A.. (9/18/17). "Press Release: First Patient Dosed in Three-month Cohort of Phase 2A Study of Oral ABX464 in HIV-supressed Patients". Paris....
[9] OSE Immunotherapeutics S.A.. (8/31/17). "Press Release: OSE Immunotherapeutics Announces Presentation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City, September 10-12, 2017". Nantes....
[10] Lysogene S.A.. (4/21/17). "Press Release: 2016 Annual Results". Paris & Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]